Investment Trusts

Hipgnosis Songs Fund Limited

SONG:LSE

Hipgnosis Songs Fund Limited

  • Price (GBX)103.05
  • Today's Change-0.552 / -0.53%
  • Shares traded775.84k
  • 1 Year change18.99%
  • Beta0.5163
Data delayed at least 20 minutes, as of Apr 26 2024 11:39 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceHipgnosis Songs Fund Limited (Ordinary Share)+20.75%
NAVHipgnosis Songs Fund Limited (Ordinary Share)-43.41%
Morningstar's BenchmarkFTSE World TR GBP--

Key statistics

As of last trade Hipgnosis Songs Fund Limited (SONG:LSE) traded at 103.05, -7.16% below its 52-week high of 111.00, set on Apr 22, 2024.
52-week range
Today
52.90Mar 04 2024111.00Apr 22 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.45bn
Market cap1.23bn GBP
Total assets1.65bn GBP
Total expense ratio8.31%
High103.80
Low103.05
Previous close103.60
Average volume62.03m
YTD Change+43.12%
Beta0.5163
Diluted NAV (est)86.74
Diluted NAV (last pub)83.72
Premium/Discount+18.25%
Net Gearing+40.39%
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateJun 29 2023
Div pay-dateJul 28 2023
Data delayed at least 20 minutes, as of Apr 26 2024 11:39 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.